• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

急性髓系白血病中通过使c-Cbl突变失活实现的Flt3依赖性转化。

Flt3-dependent transformation by inactivating c-Cbl mutations in AML.

作者信息

Sargin Bülent, Choudhary Chunaram, Crosetto Nicola, Schmidt Mirko H H, Grundler Rebekka, Rensinghoff Marion, Thiessen Christine, Tickenbrock Lara, Schwäble Joachim, Brandts Christian, August Benjamin, Koschmieder Steffen, Bandi Srinivasa Rao, Duyster Justus, Berdel Wolfgang E, Müller-Tidow Carsten, Dikic Ivan, Serve Hubert

机构信息

Department of Medicine, Hematology and Oncology, and Interdisciplinary Center for Clinical Research, University Hospital Münster, Albert-Schweitzer-Strasse 33, 48129 Münster, Germany.

出版信息

Blood. 2007 Aug 1;110(3):1004-12. doi: 10.1182/blood-2007-01-066076. Epub 2007 Apr 19.

DOI:10.1182/blood-2007-01-066076
PMID:17446348
Abstract

In acute myeloid leukemia (AML), mutational activation of the receptor tyrosine kinase (RTK) Flt3 is frequently involved in leukemic transformation. However, little is known about a possible role of highly expressed wild-type Flt3 in AML. The proto-oncogene c-Cbl is an important regulator of RTK signaling, acting through its ubiquitin ligase activity and as a platform for several signaling adaptor molecules. Here, we analyzed the role of c-Cbl in Flt3 signal transduction and myeloid transformation. C-Cbl physically interacted with Flt3 and was tyrosine phosphorylated in the presence of Flt3-ligand (FL). Overexpression of a dominant-negative form of c-Cbl (Cbl-70Z) inhibited FL-induced Flt3 ubiquitylation and internalization, indicating involvement of c-Cbl in Flt3 signaling. DNA sequencing of AML bone marrow revealed a case with a c-Cbl point mutation (Cbl-R420Q). Cbl-R420Q inhibited Flt3 internalization and ubiquitylation. Coexpression of Cbl-R420Q or Cbl-70Z with Flt3 induced cytokine-independent growth and survival of 32Dcl3 cells in the absence of FL. Also, the mutant Cbl proteins altered the amplitude and duration of Flt3-dependent signaling events. Our results indicate an important role of Cbl proteins in Flt3 signal modulation. Also, the data suggest a novel mechanism of leukemic transformation in AML by mutational inactivation of negative RTK regulators.

摘要

在急性髓系白血病(AML)中,受体酪氨酸激酶(RTK)Flt3的突变激活常常参与白血病转化过程。然而,对于高表达野生型Flt3在AML中可能发挥的作用却知之甚少。原癌基因c-Cbl是RTK信号传导的重要调节因子,通过其泛素连接酶活性发挥作用,并作为几种信号衔接分子的平台。在此,我们分析了c-Cbl在Flt3信号转导和髓系转化中的作用。c-Cbl与Flt3发生物理相互作用,并在存在Flt3配体(FL)的情况下发生酪氨酸磷酸化。显性负性形式的c-Cbl(Cbl-70Z)的过表达抑制了FL诱导的Flt3泛素化和内化,表明c-Cbl参与Flt3信号传导。AML骨髓的DNA测序显示了一例c-Cbl点突变(Cbl-R420Q)的病例。Cbl-R420Q抑制了Flt3的内化和泛素化。Cbl-R420Q或Cbl-70Z与Flt3共表达在无FL的情况下诱导32Dcl3细胞的细胞因子非依赖性生长和存活。此外,突变的Cbl蛋白改变了Flt3依赖性信号事件的幅度和持续时间。我们的结果表明Cbl蛋白在Flt3信号调节中起重要作用。此外,数据提示了AML中通过RTK负调节因子的突变失活导致白血病转化的新机制。

相似文献

1
Flt3-dependent transformation by inactivating c-Cbl mutations in AML.急性髓系白血病中通过使c-Cbl突变失活实现的Flt3依赖性转化。
Blood. 2007 Aug 1;110(3):1004-12. doi: 10.1182/blood-2007-01-066076. Epub 2007 Apr 19.
2
CBL exon 8/9 mutants activate the FLT3 pathway and cluster in core binding factor/11q deletion acute myeloid leukemia/myelodysplastic syndrome subtypes.CBL外显子8/9突变体激活FLT3通路,并聚集在核心结合因子/11q缺失急性髓系白血病/骨髓增生异常综合征亚型中。
Clin Cancer Res. 2009 Apr 1;15(7):2238-47. doi: 10.1158/1078-0432.CCR-08-1325. Epub 2009 Mar 10.
3
Novel oncogenic mutations of CBL in human acute myeloid leukemia that activate growth and survival pathways depend on increased metabolism.人类急性髓细胞性白血病中 CBL 的新型致癌突变激活了生长和存活途径,这依赖于增加的代谢。
J Biol Chem. 2010 Oct 15;285(42):32596-605. doi: 10.1074/jbc.M110.106161. Epub 2010 Jul 9.
4
E3 ligase-defective Cbl mutants lead to a generalized mastocytosis and myeloproliferative disease.E3 连接酶缺陷型 Cbl 突变体导致全身性肥大细胞增多症和骨髓增殖性疾病。
Blood. 2009 Nov 5;114(19):4197-208. doi: 10.1182/blood-2008-12-190934. Epub 2009 Sep 4.
5
Casitas B-lineage lymphoma mutants activate AKT to induce transformation in cooperation with class III receptor tyrosine kinases.卡西亚斯 B 细胞淋巴瘤突变体通过激活 AKT 与 III 类受体酪氨酸激酶协同诱导转化。
Exp Hematol. 2013 Mar;41(3):271-80.e4. doi: 10.1016/j.exphem.2012.10.016. Epub 2012 Nov 2.
6
Constitutive c-jun N-terminal kinase activity in acute myeloid leukemia derives from Flt3 and affects survival and proliferation.急性髓系白血病中组成型c-jun氨基末端激酶活性源自Flt3,并影响生存和增殖。
Exp Hematol. 2006 Oct;34(10):1360-76. doi: 10.1016/j.exphem.2006.05.019.
7
Src-Like adaptor protein (SLAP) binds to the receptor tyrosine kinase Flt3 and modulates receptor stability and downstream signaling.Src 样衔接蛋白(SLAP)与受体酪氨酸激酶 Flt3 结合,调节受体稳定性和下游信号转导。
PLoS One. 2012;7(12):e53509. doi: 10.1371/journal.pone.0053509. Epub 2012 Dec 31.
8
PRL2 phosphatase enhances oncogenic FLT3 signaling via dephosphorylation of the E3 ubiquitin ligase CBL at tyrosine 371.PRL2 磷酸酶通过去磷酸化 E3 泛素连接酶 CBL 上的酪氨酸 371 增强致癌性 FLT3 信号。
Blood. 2023 Jan 19;141(3):244-259. doi: 10.1182/blood.2022016580.
9
Loss of c-Cbl E3 ubiquitin ligase activity enhances the development of myeloid leukemia in FLT3-ITD mutant mice.c-Cbl E3泛素连接酶活性的丧失会增强FLT3-ITD突变小鼠中髓系白血病的发展。
Exp Hematol. 2015 Mar;43(3):191-206.e1. doi: 10.1016/j.exphem.2014.11.009. Epub 2014 Dec 19.
10
c-Cbl and Cbl-b ligases mediate 17-allylaminodemethoxygeldanamycin-induced degradation of autophosphorylated Flt3 kinase with internal tandem duplication through the ubiquitin proteasome pathway.c-Cbl 和 Cbl-b 连接酶通过泛素蛋白酶体途径介导 17-烯丙基氨基去甲氧基格尔德霉素诱导的 Flt3 激酶自身磷酸化内部串联重复结构域的降解。
J Biol Chem. 2011 Sep 2;286(35):30263-30273. doi: 10.1074/jbc.M111.232348. Epub 2011 Jul 18.

引用本文的文献

1
Development and preclinical characterization of AMG 329: a human antibody neutralizing FLT3 ligand.AMG 329的研发及临床前特性研究:一种可中和FLT3配体的人源抗体
MAbs. 2025 Dec;17(1):2527677. doi: 10.1080/19420862.2025.2527677. Epub 2025 Jul 7.
2
Profound phenotypic deficiencies in mature blood and bone marrow progenitor dendritic cells in chronic lymphocytic leukemia patients.慢性淋巴细胞白血病患者成熟血液及骨髓祖细胞来源的树突状细胞存在显著的表型缺陷。
Leukemia. 2025 Jun 26. doi: 10.1038/s41375-025-02579-6.
3
A microglia clonal inflammatory disorder in Alzheimer's disease.
阿尔茨海默病中的一种小胶质细胞克隆性炎症性疾病。
Elife. 2025 Mar 14;13:RP96519. doi: 10.7554/eLife.96519.
4
Autoinflammation in patients with leukocytic CBL loss of heterozygosity is caused by constitutive ERK-mediated monocyte activation.白细胞 CBL 杂合性缺失患者的自身炎症是由组成性 ERK 介导的单核细胞激活引起的。
J Clin Invest. 2024 Oct 15;134(20):e181604. doi: 10.1172/JCI181604.
5
Profound deficiencies in mature blood and bone marrow progenitor dendritic cells in Chronic Lymphocyticcytic Leukemia patients.慢性淋巴细胞白血病患者成熟血液和骨髓祖细胞树突状细胞存在严重缺陷。
Res Sq. 2024 Sep 27:rs.3.rs-4953853. doi: 10.21203/rs.3.rs-4953853/v1.
6
CBL mutations in chronic myelomonocytic leukemia often occur in the RING domain with multiple subclones per patient: Implications for targeting.慢性粒单核细胞白血病中的 CBL 突变常发生在 RING 结构域,每个患者有多个亚克隆:靶向治疗的意义。
PLoS One. 2024 Sep 19;19(9):e0310641. doi: 10.1371/journal.pone.0310641. eCollection 2024.
7
Exploiting the potential of the ubiquitin-proteasome system in overcoming tyrosine kinase inhibitor resistance in chronic myeloid leukemia.利用泛素-蛋白酶体系统在克服慢性髓性白血病中酪氨酸激酶抑制剂耐药性方面的潜力。
Genes Dis. 2023 Oct 26;11(5):101150. doi: 10.1016/j.gendis.2023.101150. eCollection 2024 Sep.
8
Elucidating the Role of Wildtype and Variant FGFR2 Structural Dynamics in (Dys)Function and Disorder.阐明野生型和变异型FGFR2结构动力学在(功能失调)和疾病中的作用。
Int J Mol Sci. 2024 Apr 20;25(8):4523. doi: 10.3390/ijms25084523.
9
Immunological and hematological findings as major features in a patient with a new germline pathogenic CBL variant.免疫和血液学表现为携带新型种系致病性 CBL 变异患者的主要特征。
Am J Med Genet A. 2024 Aug;194(8):e63627. doi: 10.1002/ajmg.a.63627. Epub 2024 Apr 12.
10
A microglia clonal inflammatory disorder in Alzheimer's Disease.阿尔茨海默病中的一种小胶质细胞克隆性炎症性疾病。
bioRxiv. 2024 Aug 3:2024.01.25.577216. doi: 10.1101/2024.01.25.577216.